Cramer Rosenthal Mcglynn LLC reduced its holdings in Xylem Inc. (NYSE:XYL) by 30.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 848,311 shares of the industrial products company’s stock after selling 365,094 shares during the quarter. Cramer Rosenthal Mcglynn LLC owned 0.47% of Xylem worth $53,130,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Harfst & Associates Inc. boosted its position in shares of Xylem by 26.1% during the second quarter. Harfst & Associates Inc. now owns 2,433 shares of the industrial products company’s stock worth $134,000 after buying an additional 503 shares during the period. FNY Partners Fund LP boosted its position in shares of Xylem by 2,700.0% during the third quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock worth $175,000 after buying an additional 2,700 shares during the period. Tower Research Capital LLC TRC acquired a new position in shares of Xylem during the second quarter worth about $168,000. Dorsey & Whitney Trust CO LLC acquired a new position in shares of Xylem during the third quarter worth about $205,000. Finally, Federated Investors Inc. PA boosted its position in shares of Xylem by 5.8% during the second quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock worth $182,000 after buying an additional 181 shares during the period. Institutional investors own 85.58% of the company’s stock.
Shares of Xylem Inc. (NYSE:XYL) traded down $0.33 during midday trading on Monday, reaching $69.01. The company had a trading volume of 674,700 shares, compared to its average volume of 1,210,300. Xylem Inc. has a 1 year low of $46.67 and a 1 year high of $69.69. The company has a quick ratio of 1.26, a current ratio of 1.76 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $12,394.20, a PE ratio of 30.14, a PEG ratio of 1.92 and a beta of 1.17.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Investors of record on Thursday, November 2nd will be given a dividend of $0.18 per share. The ex-dividend date is Wednesday, November 1st. This represents a $0.72 annualized dividend and a yield of 1.04%. Xylem’s dividend payout ratio (DPR) is presently 41.86%.
XYL has been the subject of several recent research reports. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $71.00 price objective (up from $64.00) on shares of Xylem in a research report on Wednesday, October 4th. Canaccord Genuity reaffirmed a “hold” rating and set a $56.00 price objective on shares of Xylem in a research report on Friday, October 6th. Boenning Scattergood reaffirmed an “outperform” rating on shares of Xylem in a research report on Tuesday, September 5th. Stifel Nicolaus reaffirmed a “hold” rating and set a $63.00 price objective on shares of Xylem in a research report on Friday, October 13th. Finally, Zacks Investment Research raised Xylem from a “hold” rating to a “buy” rating and set a $71.00 price objective for the company in a research report on Thursday, October 5th. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Xylem has an average rating of “Buy” and an average price target of $65.17.
In other Xylem news, Director Steven R. Loranger sold 37,700 shares of the company’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $66.25, for a total value of $2,497,625.00. Following the sale, the director now owns 58,831 shares in the company, valued at $3,897,553.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Colin R. Sabol sold 38,070 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $65.81, for a total value of $2,505,386.70. Following the completion of the sale, the insider now owns 61,979 shares in the company, valued at approximately $4,078,837.99. The disclosure for this sale can be found here. Insiders have sold 83,270 shares of company stock valued at $5,501,312 over the last three months. Insiders own 0.75% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This article was reported by Community Financial News and is the property of of Community Financial News. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.com-unik.info/2017/12/04/xylem-inc-xyl-holdings-lessened-by-cramer-rosenthal-mcglynn-llc.html.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
What are top analysts saying about Xylem Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Xylem Inc. and related companies.